Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Richter

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|July 10, 2024
'X' marks the spot! Utilising factor Xa inhibitors to optimise thromboprophylaxis in multiple myelomaThomaz Alexandre Costa, Nicole Felix, Joshua Richter
Targeted Oncology|June 30, 2022
What's Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple MyelomaBruno Almeida Costa, Tarek H Mouhieddine, Joshua Richter
Seminars in Hematology|January 29, 2025
Advancements in bispecific antibodies for multiple myeloma: What's new and what lies aheadTarek H Mouhieddine, Bruno Almeida Costa, Joshua Richter
Blood Reviews|September 22, 2022
No needles needed: All-oral therapy options for relapsed and refractory multiple myelomaJoseph Franz, Elizabeth Myrus, Larysa Sanchez, et al.
Therapeutic Advances in Hematology|June 23, 2020
Selinexor in relapsed/refractory multiple myelomaJoshua Richter, Deepu Madduri, Shambavi Richard, et al.
Seminars in Oncology|January 8, 2017
Optimal treatment strategies in myeloma: An argument against maintenance therapy after autologous stem cell transplantationJoshua Richter, Noa Biran, David Vesole, et al.
Expert Opinion on Biological Therapy|February 9, 2025
An evaluation of linvoseltamab for treatment of relapsed/refractory multiple myelomaZachary M Avigan, Mohammad A Rattu, Joshua Richter
Frontiers in Oncology|July 3, 2023
Editorial: T-cell directed therapies in multiple myelomaJoshua Richter, Larry D Anderson, Karthik Ramasamy, et al.
Ejhaem|November 29, 2023
Real-world multiple myeloma front-line treatment and outcomes by transplant in the United StatesJoshua Richter, Darren Pan, Taylor Salinardi, et al.
Therapeutic Advances in Hematology|April 2, 2021
B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapiesLarysa Sanchez, Alexandra Dardac, Deepu Madduri, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|July 10, 2024
'X' marks the spot! Utilising factor Xa inhibitors to optimise thromboprophylaxis in multiple myelomaThomaz Alexandre Costa, Nicole Felix, Joshua Richter
Targeted Oncology|June 30, 2022
What's Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple MyelomaBruno Almeida Costa, Tarek H Mouhieddine, Joshua Richter
Seminars in Hematology|January 29, 2025
Advancements in bispecific antibodies for multiple myeloma: What's new and what lies aheadTarek H Mouhieddine, Bruno Almeida Costa, Joshua Richter
Blood Reviews|September 22, 2022
No needles needed: All-oral therapy options for relapsed and refractory multiple myelomaJoseph Franz, Elizabeth Myrus, Larysa Sanchez, et al.
Therapeutic Advances in Hematology|June 23, 2020
Selinexor in relapsed/refractory multiple myelomaJoshua Richter, Deepu Madduri, Shambavi Richard, et al.
Seminars in Oncology|January 8, 2017
Optimal treatment strategies in myeloma: An argument against maintenance therapy after autologous stem cell transplantationJoshua Richter, Noa Biran, David Vesole, et al.
Expert Opinion on Biological Therapy|February 9, 2025
An evaluation of linvoseltamab for treatment of relapsed/refractory multiple myelomaZachary M Avigan, Mohammad A Rattu, Joshua Richter
Frontiers in Oncology|July 3, 2023
Editorial: T-cell directed therapies in multiple myelomaJoshua Richter, Larry D Anderson, Karthik Ramasamy, et al.
Ejhaem|November 29, 2023
Real-world multiple myeloma front-line treatment and outcomes by transplant in the United StatesJoshua Richter, Darren Pan, Taylor Salinardi, et al.
Therapeutic Advances in Hematology|April 2, 2021
B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapiesLarysa Sanchez, Alexandra Dardac, Deepu Madduri, et al.
Pageof 13